default

Request a Quote

We are currently upgrading our website. You may experience delays or limited access to certain features.
Thank you for your patience as we enhance your experience!

Industry Insights

  1. September 09, 2024

    Reducing Risk with Strep B Carrot Broth™: Combatting Newborn GBS Infections

    The birthrate in the United States has hit a new record low, according to an analysis of 2023 birth certificate data published this past spring by the Centers for Disease Control and Prevention (CDC). Last year’s slowdown marks an end to the uptick in new babies that began during...

    Read More
  2. September 03, 2024

    Mpox Outbreak Classified as Global Public Health Emergency

    On Wednesday, August 14, 2024, the World Health Organization (WHO) declared that the most recent mpox, formerly known as monkeypox, outbreak in Africa is a global health emergency. “This is something that should concern us all ... The potential for further spread within Africa and beyond is very worrying,” said WHO Director-General Dr. Tedros Adhanom Ghebreyesus.

    To aid in the testing procedures...

    Read More
  3. August 06, 2024

    Alexander Fleming: A Pioneer for Antimicrobial Stewardship

    Explore the remarkable life of Sir Alexander Fleming, the man behind penicillin, in our latest blog post. Born in 1881 in Scotland, Fleming's journey from a marksman in the Territorial Army to a Nobel laureate revolutionized modern medicine. Discover his accidental discovery of penicillin and its profound impact on global health. Dive into the history and personal stories that shaped one of the greatest...

    Read More
  4. July 29, 2024

    The Power of Copper: An Ally in the Fight Against Resistant Bacteria

    Scientists are continually seeking new weapons in the arms race against increasingly resistant bacteria. One of our oldest weapons, copper, may hold the key to curbing the rise of these superbugs...

    Read More
  5. July 22, 2024

    AMR: An Evolving Global Health Threat

    The World Health Organization (WHO) recently released its 2024 Bacterial Priority Pathogens List (BPPL). The 72-page document builds on its first list, released in 2017. The WHO BPPL 2024 focuses on the antibiotic-resistant bacteria that present the greatest unmet needs and pose the most significant public health burdens. The list includes 15 families of antibiotic resistant pathogens grouped as critical...

    Read More
  6. July 15, 2024

    Tuberculosis: Still the Deadliest Infectious Disease in the World

    For a human pathogen with no known environmental reservoir, Mycobacterium tuberculosis has honed the art of survival and has persisted in human communities from antiquity through modern times. Tuberculosis is a preventable and treatable infectious disease. Having said that, it is still one of the major contributors to morbidity and mortality in developing countries where there is less-than-adequate...

    Read More
  7. July 01, 2024

    Is progress being made against Cystic Fibrosis?

    We’re all familiar with this ever-present dichotomy. Antibiotics are life-saving, until they’re not; until the delicate balance shifts, causing the oh-so-inevitable resistance. While antibiotic stewardship programs are becoming more and more prevalent, what does one do when working with a patient with a chronic condition in which daily, long-term antimicrobial treatment is the norm? How do we address...

    Read More
  8. June 24, 2024

    Early antibiotic use increases risk of colon cancer

    In a large genetic analysis study, individuals with genetic risk factors, such as family history of colorectal cancer (CRC), who have experienced early-life antibiotic use on a long term basis, demonstrated an increased risk of early-onset CRC. It was determined that individuals with a high polygenic risk score (genetic predisposition to a particular disease) were at higher risk of early-onset CRC...

    Read More
  9. May 21, 2024

    Pan-Resistant Candida auris

    The CDC attributes the rise in C. auris cases during the height of the pandemic as a result of inadequate staffing, supply shortages, the increased number of seriously ill patients, and changes in infection prevention and control practices. The CDC encourages all U.S. laboratories that identify C. auris to notify their state or local public health authorities. ...

    Read More
  10. April 10, 2024

    Meningococcal Meningitis on the Rise

    The CDC is alerting doctors to be on the lookout for certain types of rare, serious meningococcal infections that are on the rise in the United States.

    This alarming increase is caused by Neisseria meningitidis bacteria, which has caused 1 in 6 people to die, a higher fatality rate than they typically see with meningococcal infections.

    These cases are also unusual because they...

    Read More
  11. April 03, 2024

    Turning the Tide: The NSCSS Task Force's Battle Against Rising Syphilis Rates

    The Centers for Disease Control and Prevention (CDC) recently released its 2022 Sexually Transmitted Infections (STI) Surveillance Report providing U.S. data for nationally notifiable STI’s for federally funded control programs.

    According...

    Read More
  12. March 14, 2024

    Why Public Health Depends Upon Antimicrobial Stewardship

    As hundreds of thousands of patients come face-to-face with health issues related to antibiotic-resistant infections, the scientific community must address the significance of antimicrobial stewardship and its core principles....

    Read More
  13. February 28, 2024

    Anaerobic Culture Media's Crucial Role in Diagnosing Unique Gas Gangrene Case

    Postoperative infections are one of the most common complications in general surgery, and rates have been reduced with the routine administration of perioperative antibiotics (1). GG is reportedly more common after penetrating trauma or major surgery and is rarely reported without obvious predisposing events, such as edema, fever, malaise, and pain. Previous documents have only...

    Read More
  14. February 05, 2024

    Mastering the Kirby-Bauer Technique: From Zones to Results

    The purpose of the Kirby-Bauer disk diffusion susceptibility test is to determine the in vitro susceptibility of bacteria and fungi to various antimicrobial compounds. It is a standardized test that can be performed in a laboratory setting and is a valuable tool for both clinicians and microbiologists...

    Read More
  15. January 12, 2024

    Cases of Group A Streptococcus Continue to Climb

    We began to see an increase in the number of strep throat cases in beginning in late spring of 2023, not only in pediatric patients, but adults as well. Now in December, cases of Group A Streptococcus (GAS) continue to rise. During one newscast out of the Midwest, some physicians say 2023 was the worst year for strep throat that they can remember...
    Read More
Page